A synthetic peptide from poliovirus coat protein VP2 can induce and prime neutralizing antibodies, suggesting potential for peptide vaccine development.
No takes yet. Share an insight, caveat, or question.
No immediate implications for human vaccination; leaves open peptide priming strategies for further preclinical testing.
Emini et al. (1984) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: